1. HBW Insight
  2. >>Beauty
  3. >>Business
  4. >>Earnings

Rejuvenated A Year Into Saunders’ Return To Helm, B+L Refreshing Blink, Lumify Lines

 
• By Malcolm Spicer

Brimonidine tartrate eye drops remain key sales driver among Canadian firm’s consumer health lines with 12% growth in the latest quarter. B+L expects pending launch of preservative-free line extension to sustain Lumify as a driver as generics of original formulation are approved.

• Source: Shutterstock

Any honeymoon expected for Brent Saunders at Bausch + Lomb, Corporation may or may not be over after a year at the helm, but the special period known as market exclusivity the firm’s Lumify OTC switch eye drops enjoyed in the US could be passing with the first generic copy approved.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Earnings

Beiersdorf Repositioning In China Will Get Boost From Thiamidol Launch

 
• By Eileen Francis

Beiersdorf AG hit some initial bumps with a repositioning of its business in China, but the firm is optimistic about the rollout of Thiamidol Skin Care In 2026.

L’Oréal, LVMH On First Quarter Challenges

 
• By Eileen Francis

L’Oréal Groupe reports in a first quarter presentation that its US business was more challenging than anticipated, while China “was slightly less bad” and Europe represented the best growth contributor. Separately, LVMH's Sephora sees ‘less momentum’ in its US business as competitor Amazon takes an aggressive position on beauty pricing.

Reducing Complexity Helps Weleda Break Sales Record

 
• By Tom Gallen

Swiss firm reports highest revenues in its history as restructure pays off for its pharma and cosmetics businesses in 2024.

Coty: Fragrance Demand Strong, But Retail Dynamics Weigh On 2025 Outlook

 
• By Eileen Francis

Coty Inc. reports fiscal second quarter sales slipped 3% on a reported basis to $1.67bn, reflecting further slowing of the mass beauty market, particularly color cosmetics.

More from Business

NAD Under New Head Marcus Targets ‘AI Washing,’ Ads For Children

 
• By Eileen Francis

The National Advertising Division will pursue advertising that boasts the benefits of artificial intelligence before those benefits are actually achieved, says new NAD head Phyllis Hurwitz Marcus in an interview.

French Agency Proposes Effective EU Ban On CBD In Foods And Cosmetics

 
• By David Ridley

France's food safety regulator ANSES is proposing a reproductive toxicity category 1B classification for CBD under the EU's CLP regulation, which would mean an effective ban on CBD in cosmetics and foods. However, French hemp industry association UIVEC hopes that new evidence coming out of a European Commission review will put the issue to bed before it gets that far.

‘Ulta Beauty In Target’ Paused As Partners Evaluate Work, Improve Upon Efficiencies – New CEO

 
• By Eileen Francis

The expansion of Ulta Beauty in Target stores are paused for now as Ulta Beauty Inc. and Target Corp. “lean into” the 610 stores already established and consider how to drive efficiencies and leverage learnings, says new President and CEO Kecia Steelman.